Archive: Ross Marchand
Ross Marchand is a Catalyst Policy Fellow and the director of policy for the Taxpayers Protection Alliance. He focuses on a range of issues, ranging from health-care reform to internet regulation to Postal Service-related issues. Ross is an alumnus of the Mercatus Center MA Fellowship at George Mason University, where he received his MA in economics in 2016. He has interned for the Texas Public Policy Foundation and the American Legislative Exchange Council, analyzing and blogging on a variety of public policy issues.
The Middle-Class Is Hollowing Out, and That’s Okay
Societies can indeed become more prosperous on the whole, even as their middle classes hollow out.
Choice and Markets Are Keys to Healthy Living
It’ll take a thriving marketplace of ideas and innovation to make America and the rest of the world a healthier place.
Market-Based Medicine Beats Grim Prognosis
America may have a dysfunctional healthcare system, but at least there’s a glimmer of hope for taxpayers and consumers.
War on Cancer Progress Depends on Market Innovation
The private sector tends to do a better job of finding the “sweet spot” for research spending, leading to blockbuster new drugs and innovation.
Swedish Model Is Far Better Than American Trillion Dollar Deficits
If left-wing Swedish politicians can boldly cut spending and taxes, the Trump administration and Congress have no excuse.
Robots Aren’t Out to Get Your Retail Job
Even as automation spreads, human labor continues to be a key component of the retail market.
Greater Ambulance Flexibility Can Save Lives and Dollars
Allowing for intensive care on site or transporting patients to urgent care clinics or regular doctors’ offices, can give patients greater peace of mind and save taxpayers billions of dollars.
Gene Replacement Can be the Cure that Patients—and Taxpayers—Have Been Looking For
Current gene therapies are just the start of a multi-decade effort to revolutionize health care and liberate billions from pain and suffering.
Genetics-Based Medicine can Save Millions of Lives and Billions of Dollars
The wider use of genetic testing to improve the prescribing of medicine has the potential to revolutionize medicine, improve countless lives, and finally bend that cost curve.